Aurinia Pharmaceuticals, Inc. (AUPH)
15.55
-0.05
(-0.32%)
USD |
NASDAQ |
May 19, 16:00
15.56
+0.01
(+0.06%)
After-Hours: 20:00
Aurinia Pharmaceuticals Cash and Short Term Investments (Quarterly) : 378.78M for March 31, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 1.095B |
| Edesa Biotech, Inc. | 10.00M |
| ProMIS Neurosciences, Inc. | 63.85M |
| Medicus Pharma Ltd. | 4.561M |
| Kiniksa Pharmaceuticals International Plc | 468.09M |